收藏 (0)CATO News
Now Available | CATO Acyclovir EP Impurity R – Empowering Antiviral Drug Quality Control
To support quality research and registration submissions, CATO's in-house developed Impurity R reference standard features high purity and high stability, complete with comprehensive Certificate of Analysis (COA), making it widely applicable for process optimization, method development, registration dossier preparation, and various other application requirements.
CATO|CATO|2025-08-25 14:42:20FDA Adds 12 High-Risk Nitrosamine Impurities, Spotlighting Meglumine-Related NDSRIs
Recently, the U.S. FDA updated its Nitrosamine Impurities Acceptable Intake Limits database, adding 12 new high-risk nitrosamine impurities. Among them, meglumine-related nitrosamine drug substance-related impurities (NDSRIs) have emerged as a major pharmaceutical safety concern, involving more than ten commonly used drugs such as delafloxacin meglumine, iopamidol meglumine, and gadodiamide meglumine.
CATO|CATO|2025-08-11 15:46:08Join us at CPHI China 2025 !
I am writing to invite to meet you in China CPHI on June 24-26, 2025, here is our Booth: # Hall E2G36. Please let me know your preferred meeting time, if you are there.
CATO|CATO|2025-08-04 11:14:55
